Precision Optics (NASDAQ:POCI) versus Endonovo Therapeutics (OTCMKTS:ENDV) Head to Head Review

Precision Optics (NASDAQ:POCI) and Endonovo Therapeutics (OTCMKTS:ENDV) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their profitability, earnings, dividends, analyst recommendations, risk, valuation and institutional ownership.

Analyst Recommendations

This is a breakdown of current recommendations and price targets for Precision Optics and Endonovo Therapeutics, as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Precision Optics	0	0	0	0	N/A
Endonovo Therapeutics	0	0	0	0	N/A

Risk & Volatility

Precision Optics has a beta of 0.13, suggesting that its share price is 87% less volatile than the S&P 500. Comparatively, Endonovo Therapeutics has a beta of -1.95, suggesting that its share price is 295% less volatile than the S&P 500.

Profitability

This table compares Precision Optics and Endonovo Therapeutics’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Precision Optics	-8.43%	-19.07%	-11.81%
Endonovo Therapeutics	4,911.97%	-29.58%	755.18%

Insider and Institutional Ownership

13.7% of Precision Optics shares are held by institutional investors. 16.3% of Precision Optics shares are held by insiders. Comparatively, 5.6% of Endonovo Therapeutics shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Valuation and Earnings

This table compares Precision Optics and Endonovo Therapeutics’ gross revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Precision Optics	$19.41 million	1.61	-$140,000.00	($0.28)	-18.43
Endonovo Therapeutics	$140,000.00	2.72	$6.93 million	N/A	N/A

Endonovo Therapeutics has lower revenue, but higher earnings than Precision Optics.

Summary

Precision Optics beats Endonovo Therapeutics on 5 of the 9 factors compared between the two stocks.

About Precision Optics

Precision Optics Corporation, Inc. designs, develops, manufactures, and sells specialized optical and illumination systems and related components primarily in the United States and the European Economic Area. It offers medical instrumentation products, including endoscopes and endocouplers, as well as other custom imaging and illumination products, such as Microprecision lenses and micro medical cameras, and 3D endoscopes for use in minimally invasive surgical procedures by hospitals and physicians. The company also provides components and assemblies for industrial and military use. It markets its products to medical device companies. The company was incorporated in 1982 and is based in Gardner, Massachusetts.

About Endonovo Therapeutics

Endonovo Therapeutics, Inc., a biotechnology company, develops, manufactures, and distributes non-invasive Electroceutical medical devices for regenerative medicine. The company offers SofPulse, a non-invasive Electroceutical therapeutic device for the palliative treatment of soft tissue injuries, chronic wounds, and post-operative pain and edema. Its Electroceuticals medical device is also used for the treatment of cardiovascular diseases, chronic kidney, liver diseases, non-alcoholic steatohepatitis, cardiovascular and peripheral artery diseases, and ischemic stroke, as well as for central nervous system disorders, such as traumatic brain injury, acute concussions, post-concussion syndrome, stroke, and multiple sclerosis. Endonovo Therapeutics, Inc. was founded in 2008 and is based in Woodland Hills, California.